Vanda Pharmaceuticals Inc. (FRA:VM4)
Germany
· Delayed Price · Currency is EUR 4.540
+0.080 (1.79%)
At close: Dec 5, 2025
Vanda Pharmaceuticals Employees
Vanda Pharmaceuticals had 368 employees as of December 31, 2024. The number of employees increased by 165 or 81.28% compared to the previous year.
Employees
368
Change (1Y)
165
Growth (1Y)
81.28%
Revenue / Employee
€491,170
Profits / Employee
€195,008
Market Cap
273.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Vanda Pharmaceuticals News
- 4 days ago - Vanda Pharma Extends FDA Re Review Timeline For Tradipitant Clinical Hold To December 5 - Nasdaq
- 5 days ago - Should You Invest in This Under-the-Radar Weight Loss Stock? - The Motley Fool
- 7 days ago - FDA Extends Review of Vanda Pharmaceuticals' (VNDA) Tradipitant - GuruFocus
- 7 days ago - FDA Fast-Tracks Vanda's Motion Sickness Drug Review After Leadership Shake-Up - Benzinga
- 7 days ago - Vanda Pharmaceuticals Announces Updated FDA Timeline For Tradipitant - Nasdaq
- 7 days ago - Vanda Pharmaceuticals (VNDA) Updates on Tradipitant for Motion Sickness - GuruFocus
- 7 days ago - Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness - PRNewsWire
- 15 days ago - Vanda Pharmaceuticals: Commercial Execution Meets Pipeline Optionality - Seeking Alpha